Risk factors analysis of atrial fibrillation after radical esophagectomy_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

TANG Jun ¹ , ZHAO Jianzhu ¹ , WANG Xiwen ¹ ,  ZHAO Jungang ¹

1. Department of Thoracic Surgery, Shengjing Hospital, China Medical University, Shenyang, 110004, P.R.China;
2. Department of Medical Oncology, Shengjing Hospital, China Medical University, Shenyang, 110004, P.R.China;

Corresponding author：

ZHAO Jungang, Email: 65015897@qq.com

Keywords：

Radical esophagectomy; atrial fibrillation; risk factor

DOI：

10.7507/1007-4848.201708046

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the risk factors of atrial fibrillation (AF) after radical esophagectomy, providing the basis for prevention and treatment of AF after radical esophagectomy. Methods We conducted a retrospective analysis of 335 patients' clinical data, who accepted laparoscopic combined thoracic or open radical esophagectomy in the same treatment group at Department of Thoracic Surgery of Shengjing Hospital of China Medical University between January 2014 and August 2016. There were 262 males and 73 females at age of 65.1 (43-78) years. Results There were 48 of 335 patients with AF within 1 week after surgery. By univariate analysis: age, gender, history of peripheral vascular disease and cardiac stents or angina pectoris, preoperative brain natriuretic peptide (BNP), preoperative left ventricular diastolic dysfunction, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion were possible risk factors. By multivariate analysis: age, gender, history of cardiac stents or angina pectoris, preoperative BNP, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion were risk factors. Conclusion The risk factors of AF after radical esophagectomy are age, gender, history of cardiac stents or angina pectoris, preoperative BNP, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion. Perioperative positive intervention to above factors may reduce the incidence of postoperative AF.

Citation： TANG Jun, ZHAO Jianzhu, WANG Xiwen, ZHAO Jungang. Risk factors analysis of atrial fibrillation after radical esophagectomy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(7): 572-576. doi: 10.7507/1007-4848.201708046 Copy

1.	Gomez-Caro A, Moradiellos MF, Ausin PF, et al. Risk factors for atrial fibrillation after thoracic surgery. Arch Bronconeumol 2006, 42:9-13.
2.	Amar D, Zhang H. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg, 2002, 95(3): 537-543.
3.	张秀锦, 李小鹰. 老年心房颤动患者抗凝治疗影响因素分析. 中华保健医学杂志, 2009, 11(3): 183-185.
4.	Amar D, Zhang H, Leung DHY, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology, 2002, 96: 352-356.
5.	Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg, 2004, 127: 779-786.
6.	Angele MK, Schwacha MG, Ayala A, et al. Effect of gender and sex hormones on immune responses following shock. Shock, 2000, 14(2): 81-90.
7.	姜衡, 魏勇, 王芹, 等. 高血压病患者发生心房颤动的相关危险因素临床分析.国际心血管病杂志, 2013, 40(1): 57-59.
8.	王志茹, 操敏, 李琦. 肺癌肺切除术后心律失常的相关因素分析. 中华临床医师杂志(电子版), 2012, 6(13): 186-187.
9.	Ojima T, Iwahashi M, Nakamori M, et al. Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today, 2014, 44: 839-847.
10.	Toufektzian L, Zisis C, Balaka C, et al. Effectiveness of brain natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing non-cardiac thoracic surgery. Interact CardioVasc Thorac Surg, 2015, 20: 654-657.
11.	Raman T, Roistacher N, Liu J, et al. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg, 2012, 143(2): 482-487.
12.	Sykes E, Karcher RE, Eisenstadt J, et al. Analytical relationships among Bolsite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol, 2005, 123(4): 584-590.
13.	Xing SY, Wang HL, Dong PS, et al. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation. Genet Mol Res, 2015, 14(2): 6953-6959.
14.	Nojiri T, Maeda H, Takeuchi Y, et al. Predictive value of B type natriuretic peptide for postoperative atrial fibrillation followinig pulmonary following pulmonary recection for lung cancer. Eur J Cardiothorac Surg, 2010, 37(4): 787-791.
15.	刘光义, 徐连芬, 王林. 电视辅助胸腔镜手术(VATS)与开胸手术治疗食管癌的疗效比较. 中国现代医生, 2015, 53(34): 46-48.
16.	孙斌, 钱宝华. 不同麻醉药物与术中输血对胰腺癌患者免疫功能的影响. 第二军医大学, 2015. 5.
17.	Moskowitz DM, Mccullouth JN, Shander A, et al. The impact of blood conservation on outcomes in caediac surgery: is it safe and effective? Ann Thorac Surg, 2010, 90(2): 451- 458.
18.	Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg, 2005, 130(2): 438-444.
19.	Gurgo AM, Ciccone AM, Dandrilli A, et al. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiol, 2008, 56(6): 581-585.
20.	王志茹, 操敏, 李琦. 肺癌肺切除术后心律失常的相关因素分析. 中华临床医师杂志:电子版, 2012, 6(13): 3745-3746.
21.	Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrilation: the Framingham Study. Am Heart J, 1983, 106(2): 389-396.
22.	Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factom. J Intern Med, 2001, 5(250): 382-389.
23.	闰宇博, 崔键, 张凯. 食管癌术后早期并发房颤的危险因素分析. 中国医刊, 2010, 45(10): 58-61.
24.	杨建江. 食管癌术后频发房颤原因分析及复律治疗. 临床合理用药, 2016, 10(9): 3-6.

1. Gomez-Caro A, Moradiellos MF, Ausin PF, et al. Risk factors for atrial fibrillation after thoracic surgery. Arch Bronconeumol 2006, 42:9-13.
2. Amar D, Zhang H. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg, 2002, 95(3): 537-543.
3. 张秀锦, 李小鹰. 老年心房颤动患者抗凝治疗影响因素分析. 中华保健医学杂志, 2009, 11(3): 183-185.
4. Amar D, Zhang H, Leung DHY, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology, 2002, 96: 352-356.
5. Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg, 2004, 127: 779-786.
6. Angele MK, Schwacha MG, Ayala A, et al. Effect of gender and sex hormones on immune responses following shock. Shock, 2000, 14(2): 81-90.
7. 姜衡, 魏勇, 王芹, 等. 高血压病患者发生心房颤动的相关危险因素临床分析.国际心血管病杂志, 2013, 40(1): 57-59.
8. 王志茹, 操敏, 李琦. 肺癌肺切除术后心律失常的相关因素分析. 中华临床医师杂志(电子版), 2012, 6(13): 186-187.
9. Ojima T, Iwahashi M, Nakamori M, et al. Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today, 2014, 44: 839-847.
10. Toufektzian L, Zisis C, Balaka C, et al. Effectiveness of brain natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing non-cardiac thoracic surgery. Interact CardioVasc Thorac Surg, 2015, 20: 654-657.
11. Raman T, Roistacher N, Liu J, et al. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg, 2012, 143(2): 482-487.
12. Sykes E, Karcher RE, Eisenstadt J, et al. Analytical relationships among Bolsite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol, 2005, 123(4): 584-590.
13. Xing SY, Wang HL, Dong PS, et al. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation. Genet Mol Res, 2015, 14(2): 6953-6959.
14. Nojiri T, Maeda H, Takeuchi Y, et al. Predictive value of B type natriuretic peptide for postoperative atrial fibrillation followinig pulmonary following pulmonary recection for lung cancer. Eur J Cardiothorac Surg, 2010, 37(4): 787-791.
15. 刘光义, 徐连芬, 王林. 电视辅助胸腔镜手术(VATS)与开胸手术治疗食管癌的疗效比较. 中国现代医生, 2015, 53(34): 46-48.
16. 孙斌, 钱宝华. 不同麻醉药物与术中输血对胰腺癌患者免疫功能的影响. 第二军医大学, 2015. 5.
17. Moskowitz DM, Mccullouth JN, Shander A, et al. The impact of blood conservation on outcomes in caediac surgery: is it safe and effective? Ann Thorac Surg, 2010, 90(2): 451- 458.
18. Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg, 2005, 130(2): 438-444.
19. Gurgo AM, Ciccone AM, Dandrilli A, et al. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiol, 2008, 56(6): 581-585.
20. 王志茹, 操敏, 李琦. 肺癌肺切除术后心律失常的相关因素分析. 中华临床医师杂志:电子版, 2012, 6(13): 3745-3746.
21. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrilation: the Framingham Study. Am Heart J, 1983, 106(2): 389-396.
22. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factom. J Intern Med, 2001, 5(250): 382-389.
23. 闰宇博, 崔键, 张凯. 食管癌术后早期并发房颤的危险因素分析. 中国医刊, 2010, 45(10): 58-61.
24. 杨建江. 食管癌术后频发房颤原因分析及复律治疗. 临床合理用药, 2016, 10(9): 3-6.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Risk factors analysis of atrial fibrillation after radical esophagectomy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content